Lv1
80 积分 2025-01-24 加入
重组人促甲状腺素介导分化型甲状腺癌的131I治疗
10个月前
已完结
头颈鳞癌KEYNOTE-689 Ⅲ期临床试验解读与启示
1年前
已关闭
Cancer of Unknown Primary Site
1年前
已完结
Treatment with hydrogen molecules prevents RANKL-induced osteoclast differentiation associated with inhibition of ROS formation and inactivation of MAPK, AKT and NF-kappa B pathways in murine RAW264.7 cells
皖公网安备34019202002308
